FrancophonIA/ELRC3.0 huggingface dataset:
English: The study enrolled 69 subjects in 5 groups: Group 1 enrolled 11 subjects who had previously received 2 doses of the A/Vietnam/1203/2004 H5N1 pandemic live attenuated influenza vaccine (P/LAIV) in 2006-2007; Group 2 enrolled 10 subjects who had previously received 2 doses of the A/Hong Kong/213/2003 H5N1 P/LAIV in 2007; Group 3 enrolled 8 subjects who had previously received 2 doses of the A/British Columbia/CN-6/2004 H7N3 P/LAIV in 2010 (as a P/LAIV control group); Groups 4 and 5 each enrolled 20 subjects who had not been previously vaccinated with LAIV and were influenza H5 naïve.
Danish: Studiet omfattede 69 forsøgspersoner i 5 grupper: Gruppe 1 omfattede 11 forsøgspersoner, som tidligere havde fået 2 doser A/Vietnam/1203/2004 H5N1 pandemisk levende svækket influenzavaccine (P/LAIV) i 20062007; Gruppe 2 omfattede 10 forsøgspersoner, som tidligere havde fået 2 doser A/Hong Kong/213/2003 H5N1 P/LAIV i 2007; Gruppe 3 omfattede 8 forsøgspersoner, som tidligere havde fået 2 doser A/British Columbia/CN-6/2004 H7N3 P/LAIV i 2010 (som en P/LAIV-kontrolgruppe); Gruppe 4 og 5 omfattede 20 forsøgspersoner, som ikke tidligere var vaccineret med LAIV, og som var influenza H5-naive.
English: Keep the nasal applicator in the outer carton in order to protect from light.
Danish: Opbevar nasalapplikatoren i den originale yderpakning for at beskytte mod lys.
English: Post-marketing data from occasional inadvertent gestational use of the seasonal vaccines offer some reassurance.
Danish: Data efter markedsføringen fra lejlighedsvis utilsigtet anvendelse af de sæsonbetingede influenzavacciner under graviditet bekræfter i en vis grad dette.
English: Similar responses were seen with P/LAIV H7N7- and H7N9-primed subjects who developed vigorous antibody responses to the corresponding wild-type viruses upon subsequent exposure to the inactivated vaccine from the same subtype.
Danish: Der sås lignende responser hos P/LAIV H7N7- og H7N9-primede forsøgspersoner, som udviklede kraftige antistofreaktioner på de tilsvarende vildtype-virusser ved efterfølgende eksponering for den inaktiverede vaccine med den samme undertype.
English: In an active-controlled clinical study (MI-CP111) conducted with T/LAIV in comparison to the injectable influenza trivalent vaccine, an increased rate of hospitalisations (for any cause) through 180 days after final vaccination dose was observed in infants 6-11 months of age (6.1% T/LAIV versus 2.6% injectable influenza vaccine).
Danish: I et aktivt kontrolleret klinisk studie (MI-CP111) udført med T/LAIV i sammenligning med den trivalente influenzavaccine til injektion blev der observeret en øget frekvens af hospitalsindlæggelser (af alle årsager) i en periode på 180 dage efter den sidste vaccinedosis hos småbørn i alderen 6-11 måneder (6,1 % T/LAIV versus 2,6 % influenzavaccine til injektion).
English: Influenza season
Danish: Influenzasæson
English: The rate of wheezing was not increased in T/LAIV recipients 24 months of age and older.
Danish: Frekvensen af hvæsende vejrtrækning var ikke øget hos T/LAIVvaccinerede i alderen 24 måneder og ældre.
English: Similarly from the VAERS, in 113 reports of pregnant women who had received AstraZeneca's (H1N1) 2009 Monovalent Vaccine Live, Intranasal, no unusual patterns of pregnancy complications or foetal outcomes were observed.
Danish: Ligeledes blev der i VAERS i 113 rapporter med gravide kvinder, som havde fået AstraZenecas (H1N1) 2009 monovalente levende, intranasale vaccine, ikke observeret nogen usædvanlige mønstre for graviditetskomplikationer eller eksponerede fostre.
English: The recommended dose for children and adolescents is 0.2 ml Pandemic influenza vaccine H5N1 AstraZeneca, administered as 0.1 ml in each nostril.
Danish: Den anbefalede dosis til børn og unge er 0,2 ml Pandemisk influenzavaccine H5N1 AstraZeneca, administreret som 0,1 ml i hvert næsebor.
English: This vaccine is presented as a nasal spray suspension in a single-use nasal applicator (0.2 ml) in a pack size of 10.
Danish: Denne vaccine findes som næsespray, suspension, i en nasalapplikator til engangsbrug (0,2 ml) i en pakningsstørrelse på 10.
English: fewer cases than injectable fewer cases than injectable
Danish: 6 til 71 mdr færre tilfælde end injicerbar færre tilfælde end injicerbar
English: Depress the plunger With a single motion, depress plunger as rapidly as possible until the dose-divider clip prevents you from going further.
Danish: Tryk stemplet ned Stemplet trykkes ned så hurtigt som muligt med en enkelt bevægelse, indtil klemmen til dosisdeling forhindrer dig i at trykke det længere ned.
English: The primary circulating strain was antigenically dissimilar from the H3N2 strain represented in the vaccine; efficacy against the mismatched A/H3N2 strain was 85.9% (95% CI: 75.3, 91.9).
Danish: Den primære cirkulerende stamme var på antigenniveau forskellig fra H3N2-stammen, der er indeholdt i vaccinen; effekten mod den ikke-matchede A/H3N2-stamme var 85,9 % (95 % CI: 75,3-91,9).
English: Non-clinical data with the Pandemic influenza vaccine H5N1 AstraZeneca, and the seasonal vaccines T/LAIV and Fluenz Tetra reveal no special hazard for humans based on conventional non-clinical studies of repeated dose toxicity, reproduction and developmental toxicity, local tolerance, and neurovirulence.
Danish: Prækliniske data for Pandemisk influenzavaccine H5N1 AstraZenecaog de sæsonbetingede vacciner T/LAIV og Fluenz Tetra viser ingen speciel risiko for mennesker vurderet ud fra konventionelle studier af toksicitet efter gentagne doser, reproduktions- og udviklingstoksicitet, lokal tolerance og neurovirulens.
English: This section describes the clinical experience observed in three pivotal studies conducted with the Pandemic influenza vaccine H5N1 AstraZeneca in adults.
Danish: Dette afsnit beskriver den kliniske erfaring observeret i tre pivotale studier udført med Pandemisk influenzavaccine H5N1 AstraZenecahos voksne.
English: Subjects who were primed with either the A/Vietnam/1203/2004 P/LAIV or the A/Hong Kong/213/2003 P/LAIV had a significantly better response to a single dose of inactivated H5N1 vaccine than P/LAIV-naïve subjects.
Danish: De forsøgspersoner, som var primet med enten A/Vietnam/1203/2004 P/LAIV eller A/Hong Kong/213/2003 P/LAIV havde et betydeligt bedre respons på en enkelt dosis inaktiveret H5N1-vaccine end P/LAIV-naive forsøgspersoner.
English: Subjects in Groups 1 to 4 received a single 45-μg dose of the A/Vietnam/1203/2004 pandemic inactivated influenza vaccine (P/IIV) while subjects in Group 5 received 2 doses, approximately 28 days apart.
Danish: Forsøgspersonerne i gruppe 1 til 4 fik en enkelt dosis på 45 μg A/Vietnam/1203/2004 pandemisk inaktiveret influenzavaccine (P/IIV), mens forsøgspersonerne i gruppe 5 fik 2 doser med ca. 28 dages mellemrum.
English: Geometric mean titer
Danish: Geometrisk middeltiter
English: From clinical studies and post-marketing surveillance with T/LAIV and Fluenz Tetra in over 110,000 children and adolescents 2 to 17 years of age, the following adverse reaction frequencies are reported: Very common (≥ 1/10)
Danish: Følgende bivirkningsfrekvenser er rapporteret fra kliniske studier med og post-marketing overvågning af T/LAIV og Fluenz Tetra hos over 110.000 børn og unge i alderen 2 til 17 år: Meget almindelig (≥ 1/10)
English: Respiratory, thoracic and mediastinal disorders Very common: Nasal congestion/rhinorrhoea Uncommon: Epistaxis
Danish: Luftveje, thorax og mediastinum Meget almindelig: Tilstoppet næse/rhinorré Ikke almindeligt: Epistaxis
English: M = months Number of study participants for year 1 or year 2 primary efficacy analysis.
Danish: USA 15 til 71 mdr mdr.= måneder Antal deltagere i studiet, der indgår i den primære effektanalyse år 1 eller år 2.
English: The incidence of wheezing within 15 days after vaccination was lower in T/LAIV recipients relative to seasonal inactivated vaccine recipients (19.5% vs. 23.8%, P=0.02).
Danish: Forekomsten af hvæsende vejrtrækning inden for 15 dage efter vaccination var lavere hos T/LAIV-vaccinerede end hos børn og unge, der blev vaccineret med den sæsonbetingede inaktiverede influenzavaccine (19,5 % vs. 23,8 %, p= 0,02).
English: Table 3 Serum microneutralization (MN) and haemagglutination inhibition (HAI) assay antibody responses on Days 28 and 56 following administration of an inactivated H5N1 vaccine
Danish: Tabel 3 Antistofrespons bestemt ved mikroneutralisering (MN)- og hæmagglutinationshæmning (HAI)-analyse i serum dag 28 og 56 efter administration af en inaktiveret H5N1-vaccine
English: For the H7N7 P/LAIV, strong serum antibody responses were detected by both MN and HAI in 9 of 13 individuals, with peak titers achieved by Day 14.
Danish: For H7N7 P/LAIV blev der påvist kraftige serumantistofreaktioner både MN og HAI hos 9 af 13 personer, med maksimale titre på dag 14.
English: The most common adverse reactions observed in clinical studies conducted with the Pandemic influenza vaccine H5N1 AstraZeneca in healthy adults was headache (25.4%) and upper respiratory infection (10.2%).
Danish: De hyppigste bivirkninger, der blev observeret i kliniske studier med Pandemisk influenzavaccine H5N1 AstraZenecahos raske voksne, var hovedpine (25,4 %) og infektion i øvre luftveje (10,2 %).
English: • The patient can breathe normally while the vaccine is being administered - there is no need to actively inhale or sniff.
Danish: • Patienten kan trække vejret normalt, mens vaccinen administreres - der er ikke behov for aktivt at inhalere eller snøfte.
English: Non-interventional post-authorisation safety study (PASS) in order to further investigate the tolerability of Pandemic influenza vaccine H5N1 AstraZeneca and estimate the incidence of adverse reactions of special interest in children and adolescents.
Danish: Ikke-interventionssikkerhedsundersøgelse efter tilladelse til markedsføring (PASS) for yderligere at undersøge tolerabiliteten af Pandemisk influenzavaccine H5N1 AstraZeneca og estimere forekomsten af bivirkninger af særlig interesse hos børn og unge.
English: Other medicines, other vaccines and Pandemic influenza vaccine H5N1 AstraZeneca Tell your doctor, nurse or pharmacist if the person being vaccinated is taking, has recently taken or might take any other medicines, including medicines that do not require a prescription.
Danish: Brug af anden medicin og andre vacciner sammen med Pandemisk influenzavaccine H5N1 AstraZeneca Fortæl det altid til lægen, apotekspersonalet eller sundhedspersonalet, hvis personen, der skal vaccineres, tager anden medicin, har gjort det for nylig eller måske vil tage anden medicin, herunder medicin, der ikke er receptpligtig.
English: In a pandemic situation, the use of Pandemic influenza vaccine H5N1 AstraZeneca in mildly to moderately immunosuppressed individuals may be considered after weighing the anticipated benefits against the potential risks for the individual.
Danish: I en pandemisk situation kan det overvejes at anvende Pandemisk influenzavaccine H5N1 AstraZenecatil personer med let til moderat immunsuppression efter individuel vurdering af de forventede fordele i forhold til de potentielle risici.
English: Seven of 11 (64%) subjects in Group 1 (ca A/Vietnam/1204/2004 [H5N1]) had ≥4-fold rises in HAI antibody titer by Day 7 following receipt of the inactivated vaccine, with a geometric mean titer (GMT) of 165 and a titer range of 20 to 1280 in responders.
Danish: Syv af 11 (64 %) forsøgspersoner i gruppe 1 (ca A/Vietnam/1204/2004 [H5N1]) havde ≥4-gange stigning i HAI-antistoftiter på dag 7 efter vaccination med den inaktiverede vaccine, med en geometrisk middeltiter (GMT) på 165 og et titerinterval på 20 til 1.280 hos respondenter.
English: The suspension is colourless to pale yellow, clear to opalescent.
Danish: Suspensionen er farveløs til svagt gullig, klar til opaliserende.
English: Södertälje Sweden
Danish: Södertälje,
English: In a study (AV010) of children and adolescents 9 to 17 years of age with moderate to severe asthma (seasonal T/LAIV: n=24, placebo: n=24), the primary safety criterion, change in percent predicted forced expiratory volume in 1 second (FEV1) measured before and after vaccination, did not differ between treatment arms.
Danish: I et studie (AV010) med børn og unge i alderen 9 til 17 år med moderat til svær astma (sæsonbetinget T/LAIV: n = 24, placebo: n = 24) var der ingen forskel mellem de 2 behandlingsarme med hensyn til det primære sikkerhedskriterie, ændring i procent forventet forceret ekspirationsvolumen i 1 sekund (FEV1) målt før og efter vaccination.
English: Clinical studies have evaluated the incidence of adverse reactions in 59 adults from 18 to 49 years of age receiving at least one dose of Pandemic influenza vaccine H5N1 AstraZeneca.
Danish: Forekomsten af bivirkninger er blevet vurderet i kliniske studier hos 59 voksne fra 18 til 49 år, som fik mindst én dosis Pandemisk influenzavaccine H5N1 AstraZeneca.
English: Immunocompromised
Danish: Immunkompromitterede patienter
English: IgA seroresponse and nasal wash response were each detected in 18% of subjects.
Danish: IgA-serorespons og respons ved nasalvask blev påvist hos 18 % af forsøgspersonerne.
English: Children and adolescents under 18 years of age receiving salicylate therapy should avoid vaccination with Pandemic influenza vaccine H5N1 AstraZeneca (see section 4.4).
Danish: Børn og unge under 18 år, som er i behandling med salicylater, bør ikke vaccineres med Pandemisk influenzavaccine H5N1 AstraZeneca (se pkt.
English: Remove dose-divider clip
Danish: Fjern klemmen til dosisdeling
English: The affinity of antibodies against the HA1 domain of the H5 HA in the H5N1 P/LAIV-primed groups was significantly higher than the 2dose inactivated vaccine group, which correlated with cross-clade H5N1 neutralisation.
Danish: Affiniteten af antistoffer mod HA1-domænet i H5 HA hos de H5N1 P/LAIV-primede grupper var signifikant højere end hos den grupper, der fik 2 doser inaktiveret vaccine, hvilket korrelerede med H5N1-krydsneutraliseringen.
English: The patient can breathe normally while the vaccine is being administered - there is no need to actively inhale or sniff.
Danish: Patienten kan trække vejret normalt, mens vaccinen administreres - der er ikke grund til at inhalere aktivt eller snøfte.
English: Ask your doctor, nurse or pharmacist if you want more information about possible side effects from Pandemic influenza vaccine H5N1 AstraZeneca.
Danish: Spørg lægen, sundhedspersonalet eller apotekspersonalet, hvis du ønsker yderligere oplysninger om bivirkninger af Pandemisk influenzavaccine H5N1 AstraZeneca.
English: The antibody response in A/Vietnam/1203/2004 P/LAIV-primed subjects also exceeded that observed after 2 doses of inactivated vaccine in P/LAIV-naïve subjects (see Table 3).
Danish: Antistofreaktionen hos A/Vietnam/1203/2004 P/LAIV-primede forsøgspersoner oversteg også det, der blev oberveret efter 2 doser inaktiveret vaccine hos P/LAIV-naive forsøgspersoner (se tabel 3).
English: • reduced appetite
Danish: • appetitløshed
English: In a study with the seasonal trivalent live attenuated influenza vaccine (T/LAIV), an increased incidence of medically significant wheezing was seen in children 12-23 months of age (see section
Danish: I et studie med sæsonbetinget trivalent levende svækket influenzavaccine (T/LAIV) blev der set en øget forekomst af klinisk relevant hvæsende vejrtrækning hos børn i alderen 12-23 måneder (se pkt.
English: T/LAIV demonstrated 64.4% (1.4, 88.8) fewer cases than injectable influenza vaccine in 476 infants and toddlers 6-23 months of age and 48.2% (12.7, 70.0) fewer cases in 1,609 children 24-71 months of age.
Danish: Der var 64,4 % (1,4, 88,8) færre tilfælde med T/LAIV end med injicerbar influenzavaccine hos 476 spædbørn og småbørn i alderen 6-23 måneder og 48,2 % (12,7, 70,0) færre tilfælde hos 1.609 børn i alderen 24-71 måneder.
English: If influenza antiviral agents and Pandemic influenza vaccine H5N1 AstraZeneca are administered concomitantly, timing and the need for revaccination should be considered based on clinical judgement.
Danish: Hvis antivirale stoffer mod influenza og Pandemisk influenzavaccine H5N1 AstraZenecaadministreres samtidigt, skal behov og tidspunkt for re-vaccination overvejes, baseret på en klinisk vurdering.
English: In order to further investigate the safety and reactogenicity of Pandemic influenza vaccine H5N1 AstraZeneca, the MAH should conduct an open-label single arm interventional study to evaluate the safety and immunogenicity of P/LAIV in children and adolescents from 12 months to less than 18 years of age during the next declared pandemic.
Danish: For yderligere at undersøge sikkerheden og reaktogeniciteten af Pandemisk influenzavaccine H5N1 AstraZeneca skal indehaveren af markedsføringstilladelsen udføre et åbent interventionsstudie med en enkelt arm for at evaluere sikkerheden og immunogeniciteten af P/LAIV hos børn og unge fra 12 måneder til under 18 år under den næste erklærede pandemi.
English: TCID50 of the vaccine intranasally in isolation, with 16 of those subjects receiving a second dose 4-8 weeks later.
Danish: TCID50 af vaccinen intranasalt i isolation, og 16 af disse forsøgspersoner fik en 2. dosis 4-8 uger senere.
English: H5N1 P/LAIV-primed subjects developed antibody responses that neutralised 2 or more clades of H5N1 viruses from the A/Goose/Guangdong/1996 H5N1 lineage, whereas few subjects even in the 2-dose inactivated H5N1 vaccine group developed cross-clade neutralising antibodies.
Danish: H5N1 P/LAIV-primede forsøgspersoner udviklede antistofresponser, der neutraliserede 2 eller flere undergrupper af H5N1-virusser fra A/Goose/Guangdong/1996 H5N1-linjen, hvorimod kun få forsøgspersoner selv i den gruppe, der fik 2 doser inaktiveret H5N1-vaccine, udviklede krydsneutraliserende antistoffer.
English: Nasal spray, suspension 10 single-use nasal applicators (0.2 ml each)
Danish: Næsespray, suspension 10 nasalapplikatorer til engangsbrug (0,2 ml hver)
English: T/LAIV demonstrated 55.7% (39.9, 67.6) fewer cases than injectable influenza vaccine in 3,686 infants and toddlers 6-23 months of age and 54.4% (41.8, 64.5) fewer cases in 4,166 children 24-59 months of age.
Danish: Der var 55,7 % (39,9, 67,6) færre tilfælde med T/LAIV end med injicerbar influenzavaccine hos 3.686 spædbørn og småbørn i alderen 6-23 måneder og 54,4 % (41,8, 64,5) færre tilfælde hos 4.166 børn i alderen 24-59 måneder.
English: Reassortant influenza virus* (live attenuated) of the following strain**:
Danish: Reassortant influenzavirus* (levende svækket) af følgende stamme**:
English: Vaccine recipients should be informed that Pandemic influenza vaccine H5N1 AstraZeneca is an attenuated live virus vaccine and has the potential for transmission to immunocompromised contacts.
Danish: De vaccinerede skal informeres om, at Pandemisk influenzavaccine H5N1 AstraZenecaer en svækket levende virusvaccine, og at der er potentiale for transmission til immunkompromitterede patienter.
English: In clinical study MI-CP217, the safety and descriptive immunogenicity of a live attenuated monovalent influenza virus vaccine (derived from A/California/7/2009) developed for the 2009 H1N1 pandemic were evaluated in a total of 326 randomised subjects (259 subjects monovalent vaccine; 65 subjects placebo) and 324 subjects received one dose of investigational product.
Danish: I det kliniske studie MI-CP217 blev sikkerhed og deskriptiv immunogenicitet af en levende svækket monovalent influenzavaccine (afledt af A/California/7/2009), udviklet til 2009 H1N1-pandemien, vurderet hos i alt 326 randomiserede forsøgspersoner, og 324 forsøgspersoner fik én dosis af det undersøgte lægemiddel (259 forsøgspersoner fik monovalent vaccine; 65 forsøgspersoner fik placebo).
English: Table 2 T/LAIV relative efficacy in active-controlled paediatric studies with seasonal injectable influenza vaccine
Danish: Tabel 2 Den relative effekt af T/LAIV i pædiatriske studier med sæsonbetinget influenzavaccine til injektion som aktiv kontrol
English: Pandemic influenza vaccine H5N1 AstraZeneca is supplied as a 0.2 ml suspension in a single-use nasal applicator (Type 1 glass), with nozzle (polypropylene with polyethylene transfer valve), nozzle tip-protector cap (synthetic rubber), plunger rod, plunger-stopper (butyl rubber), and a dose-divider clip.
Danish: Pandemisk influenzavaccine H5N1 AstraZenecaleveres som en 0,2 ml suspension i en nasalapplikator (type 1-glas) til engangsbrug, med spids (polypropylen med overførselsventil af polyethylen), beskyttelseshætte til spidsen (syntetisk gummi), stempelstang, stempel (butylgummi) og en klemme til dosisdeling.
English: Your doctor, nurse or pharmacist will decide if Pandemic influenza vaccine H5N1 AstraZeneca can be given at the same time as other vaccines.
Danish: Lægen, sundhedspersonalet eller apotekspersonalet vil afgøre, om Pandemisk influenzavaccine H5N1 AstraZenecakan gives samtidig med andre vacciner.
English: If any of these apply, tell your doctor, nurse or pharmacist before vaccination.
Danish: Hvis noget af dette gælder for dig, skal du fortælle det til lægen, sundhedspersonalet eller apotekspersonalet før vaccinationen.
English: In previously unvaccinated study participants who received one dose in year 1, efficacy was 57.7% (95% CI: 44.7, 67.9) against matched strains and 56.3% (95% CI: 43.1, 66.7) against all strains regardless of match, respectively, thus supporting the need for two doses of vaccine in previously unvaccinated children.
Danish: Hos tidligere uvaccinerede studiedeltagere, som fik en dosis år 1, var effekten henholdsvis 57,7 % (95 % CI: 44,7-67,9) mod matchede stammer og 56,3 % (95 % CI: 43,1-66,7) mod alle stammer uanset match, hvilket understøtter nødvendigheden af to vaccinedoser til tidligere ikke-vaccinerede børn.
English: PACK SIZE OF 10 SINGLE-USE NASAL APPLICATORS (IN TRAYS)
Danish: PAKNINGSSTØRRELSE PÅ 10 NASALAPPLIKATORER TIL ENGANGSBRUG (I BAKKER)
English: median tissue culture infectious dose (TCID50) , with 18 of those subjects receiving a second dose 4-8 weeks later.
Danish: TCID50 (median tissue culture infective dose); 18 af disse forsøgspersoner fik en 2. dosis 4-8 uger senere.
English: There are no data with Pandemic influenza vaccine H5N1 AstraZeneca in children and adolescents younger than 18 years of age receiving salicylate therapy.
Danish: Der foreligger ingen data for Pandemisk influenzavaccine H5N1 AstraZenecahos børn og unge under 18 år, som er i behandling med salicylater.
English: For children regardless of baseline serostatus, seroresponse rates after receipt of monovalent vaccine were 7.8% and 11.1% for Days 15 and 29, respectively, and 32.0% on Day 57.
Danish: Efter indgivelse af monovalent vaccine var seroresponsraterne 7,8 % og 11,1 % på henholdsvis dag 15 og 29 og 32,0 % på dag 57 uanset børnenes serostatus ved baseline.
English: The assessment of the safety profile for Pandemic influenza vaccine H5N1 AstraZeneca is based on a limited number of adult subjects.
Danish: Vurderingen af sikkerhedsprofilen for Pandemisk influenzavaccine H5N1 AstraZenecaer baseret på et begrænset antal voksne forsøgspersoner.
English: Antibody responses in P/LAIV H5N1-primed subjects were also broader.
Danish: Antistofresponset hos P/LAIV H5N1primede forsøgspersoner var også bredere.
English: Corresponding rates for infants and toddlers 12-23 months of age were 5.4% and 3.6% for T/LAIV and injectable influenza vaccine, respectively.
Danish: Tilsvarende frekvenser for spædbørn og småbørn i alderen 1223 måneder var 5,4 % og 3,6 % for henholdsvis T/LAIV og influenzavaccine til injektion.
English: The co-administration of Pandemic influenza vaccine H5N1 AstraZeneca with inactivated vaccines or with the seasonal vaccine Fluenz Tetra has not been studied.
Danish: Samtidig administration af Pandemisk influenzavaccine H5N1 AstraZenecaog inaktiverede vacciner eller den sæsonbetingede influenzavaccine Fluenz Tetra er ikke undersøgt.
English: After 1 or 2 doses of TCID50 vaccine, haemagglutination inhibition (HAI) and IgA seroresponses were each detected in 10% subjects, and nasal wash IgA responses were detected in 24% subjects.
Danish: Efter 1 eller 2 doser af 10 TCID50-vaccinen blev HAI-(hæmagglutinationshæmning) respons (HAI) og IgA-serorespons begge påvist hos 10 % af forsøgspersonerne, og IgA-respons ved nasalvask blev påvist hos 24 % af forsøgspersonerne.